P2.09. JIN-A04, Highly Effective and Brain-penetrant Tyrosine Kinase Inhibitor Targeting HER2 Exon20 Insertion Mutations in NSCLC - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Mi Ra Yu
Meta Tag
Speaker Mi Ra Yu
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
metastatic non-small cell lung cancer
HER2 exon20 insertion mutations
lung cancer treatment
brain metastases
anti-tumor activity
tumor xenograft models
therapeutic opportunity
targeted therapies
Powered By